Caput Medusae – Causes, Symptoms and Treatment

What is Caput medusae?

Caput medusae (Latin for "head of Medusa") is a clinical sign characterized by the visible dilation of veins around the navel, forming a radial pattern that resembles the snake-covered head of the mythological figure Medusa. It is a hallmark indicator of portal hypertension -- an abnormally elevated blood pressure within the portal venous system -- most commonly associated with severe liver disease.

Causes

Caput medusae develops when blood flow through the liver is impeded, forcing blood to seek alternative pathways back to the heart. The most common underlying causes include:

• Liver cirrhosis: The leading cause, frequently resulting from chronic alcohol use, viral hepatitis (hepatitis B or C), or non-alcoholic fatty liver disease.
• Portal hypertension: Elevated pressure in the portal venous system that drives the formation of collateral (bypass) vessels.
• Budd-Chiari syndrome: Thrombosis of the hepatic veins, obstructing blood outflow from the liver.
• Portal vein thrombosis: A blood clot in the portal vein that blocks blood flow into the liver.
• Right-sided heart failure: In rare cases, venous backpressure from cardiac insufficiency may contribute to portal hypertension.

Mechanism of Development

Under normal circumstances, blood from the gastrointestinal tract flows through the portal vein into the liver, then via the hepatic veins into the inferior vena cava and back to the heart. When portal hypertension develops, pressure in the portal vein rises significantly. In response, portosystemic collaterals -- connections between the portal and systemic venous systems that are normally dormant -- open up. The paraumbilical veins surrounding the navel are part of this collateral network: they dilate and become visible beneath the skin, producing the characteristic appearance of Caput medusae.

Symptoms and Associated Findings

Caput medusae itself is painless, but it is an important warning sign of serious underlying disease. It is often accompanied by other features of advanced liver disease:

• Ascites: Accumulation of fluid in the abdominal cavity, causing abdominal distension.
• Jaundice (icterus): Yellowing of the skin and eyes due to elevated bilirubin levels.
• Splenomegaly: Enlargement of the spleen.
• Esophageal varices: Varicose-like dilations of the esophageal veins that carry a high risk of life-threatening bleeding.
• Palmar erythema: Redness of the palms of the hands.
• Spider angiomas (spider naevi): Small, spider-shaped vascular lesions on the skin.
• General fatigue, unintentional weight loss, and loss of appetite.

Diagnosis

Caput medusae is primarily diagnosed through physical examination, during which the physician inspects the abdominal wall and identifies the characteristic venous pattern. Further investigations are carried out to determine the underlying cause:

• Blood tests: Liver enzymes (AST, ALT, GGT, bilirubin), complete blood count, coagulation parameters, and albumin levels reflect liver function.
• Abdominal ultrasound: Evaluates the liver, spleen, and portal vein, and detects ascites or thrombosis.
• Doppler ultrasound: Measures blood flow velocity in the portal vein to assess portal hypertension.
• CT scan or MRI: Provides detailed imaging of the abdominal organs and vascular structures.
• Endoscopy: Examines the esophagus and stomach for varices.
• Liver biopsy: Obtains a tissue sample for precise characterization of the liver disease.

Treatment

Caput medusae itself does not require direct treatment; therapy is directed at the underlying disease and management of portal hypertension:

Treating the Underlying Disease

• Alcoholic liver cirrhosis: strict alcohol abstinence.
• Viral hepatitis: antiviral therapy (e.g., direct-acting antivirals for hepatitis C).
• Fatty liver disease: weight loss, dietary modification, and management of comorbidities such as diabetes and dyslipidaemia.

Managing Portal Hypertension

• Beta-blockers (e.g., propranolol, carvedilol): reduce portal pressure and lower the risk of variceal bleeding.
• Transjugular intrahepatic portosystemic shunt (TIPS): an interventional radiological procedure that creates a connection between the portal vein and a hepatic vein to reduce portal pressure.
• Diuretics: treatment of ascites using medications such as spironolactone or furosemide.
• Liver transplantation: the only curative option in cases of severe, end-stage liver disease.

When to See a Doctor

Visibly dilated veins around the abdomen should always be evaluated by a physician. Medical attention is especially urgent when accompanied by jaundice, severe abdominal pain, vomiting of blood, or black tarry stools, as these may indicate life-threatening complications such as variceal hemorrhage.

References

1. Schiff, E. R., Maddrey, W. C., Sorrell, M. F. (eds.) - Schiff's Diseases of the Liver, 12th edition, Wiley-Blackwell, 2018.
2. European Association for the Study of the Liver (EASL) - EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. Journal of Hepatology, 2022. Available at: https://www.journal-of-hepatology.eu
3. Runyon, B. A. - Management of adult patients with ascites due to cirrhosis. Hepatology, 2013; 57(4): 1651-1653. Available at: https://pubmed.ncbi.nlm.nih.gov